Comments

ALPS Medical Breakthroughs ETF Stock Price, Quotes and Forecasts

SBIOARCA
Logo brought to you by Benzinga Data
PerksBuyCompare Brokers
PerksBuyCompare Brokers
$28.90
At close: Apr 28 EDT

Overview

NewsHoldingsDividendsShort Interest
Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score
Sector
Healthcare
Region
US
AUM
82.39M
Fund Score

ALPS Medical Breakthroughs ETF Price, Quotes and Forecasts | ARCA:SBIO | Benzinga

Explore ALPS Medical Breakthroughs ETF stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for SBIO.

Open-
High-
52 Wk High$42.73
AUM82.39M
Dividend$0.62
Ex-Div DateDec 19, 2024
Volume-
Market Cap$4.03B
Mgmt Fee0.5%
P/E Ratio12.58
Prev. Close$28.90
Low-
52 Wk Low$22.33
Shares Out3.20M
Yield2.15%
Div. FreqAnnual
Avg. Volume Daily18.23K
Beta0.86
Avg. Expense Ratio0.5%
P/B Ratio3.27

Recent News

FAQ

Q

How do I buy ALPS Medical Breakthroughs ETF (SBIO) stock?

A

You can purchase shares of ALPS Medical Breakthroughs ETF (ARCA:SBIO) through any online brokerage.

View our list of the best stock brokerages

Q

Who are ALPS Medical Breakthroughs ETF (SBIO) competitors?

A

There are no as such competitors for ALPS Medical Breakthroughs ETF.

Q

What is the forecast, or price target, for ALPS Medical Breakthroughs ETF (SBIO) stock?

A

There is no analysis for ALPS Medical Breakthroughs ETF to provide a consensus price target.

Q

What is the current price for ALPS Medical Breakthroughs ETF (SBIO)?

A

The stock price for ALPS Medical Breakthroughs ETF (ARCA: SBIO) is $28.9 last updated April 28, 2025 at 8:00 PM EDT.

Q

Does ALPS Medical Breakthroughs ETF (SBIO) pay a dividend?

A

There are no upcoming dividends for ALPS Medical Breakthroughs ETF.

Q

When is ALPS Medical Breakthroughs ETF (ARCA:SBIO) reporting earnings?

A

ALPS Medical Breakthroughs ETF does not have any upcoming earnings scheduled.

Q

Is ALPS Medical Breakthroughs ETF (SBIO) going to split?

A

There is no upcoming split for ALPS Medical Breakthroughs ETF.

Open-
High-
52 Wk High$42.73
AUM82.39M
Dividend$0.62
Ex-Div DateDec 19, 2024
Volume-
Market Cap$4.03B
Mgmt Fee0.5%
P/E Ratio12.58
Prev. Close$28.90
Low-
52 Wk Low$22.33
Shares Out3.20M
Yield2.15%
Div. FreqAnnual
Avg. Volume Daily18.23K
Beta0.86
Avg. Expense Ratio0.5%
P/B Ratio3.27
About ALPS ETF Trust
Sector
N/A
Industry
N/A
Got Questions? Ask
What are SBIO's Bollinger Band values?
What is SBIO's dividend yield?
What is SBIO's drawdown from recent high?
What is SBIO's free cash flow?
What is the consensus rating for SBIO?
Powered By
ETF Details
SectorHealthcare
CategoryHigh Performer-High Growth
Investment StyleSmall Cap Growth
Fund InceptionDec 30, 2014
Managers
Charles Perkins
Andrew Hicks
Ryan Mischke
DefinitionAn equity fund portfolio full of stocks with both strong financial performance and superior growth potential
Investment Policy
The fund employs a passive management - or indexing - investment approach designed to track the performance of the underlying index. It will normally invest at least 80% of its net assets in securities that comprise the underlying index. The underlying index is comprised of small- and mid-cap stocks of biotechnology companies that have one or more drugs in either Phase II or Phase III of the U.S. Food and Drug Administration clinical trials.
Top ETF Holdings
SymbolNameShare %
PCVXVaxcyte Inc5.18%
CERECerevel Therapeutics H...5.04%
VKTXViking Therapeutics In...4.45%
RVMDRevolution Medicines I...4.30%
SMMTSummit Therapeutics Pl...4.14%
IEAlkermes Plc4.84%
AXSMAxsome Therapeutics, I...4.65%
CRNXCrinetics Pharmaceutic...2.65%
CORTCorcept Therapeutics I...2.13%
MRUSMerus Nv2.10%
VRNAVerona Pharma Plc4.53%
PTCTPtc Therapeutics Inc3.44%
ZLABZai Lab Ltd3.66%
RNAAvidity Biosciences In...3.00%
AKROAkero Therapeutics Inc2.90%
RYTMRhythm Pharmaceuticals...2.97%
ACADAcadia Pharmaceuticals...2.69%
PTGXProtagonist Therapeuti...2.79%

Connect With Us

instagramlinkedinyoutube

About Benzinga

Market Resources

Trading Tools & Education

Ring the Bell

© 2025 Benzinga | All Rights Reserved